Top

Reproductive Biology and Endocrinology

Published in:

Open Access 01-12-2017 | Research

Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA

Authors: Alice J. Shapiro, Sarah K. Darmon, David H. Barad, David F. Albertini, Norbert Gleicher, Vitaly A. Kushnir

Published in: Reproductive Biology and Endocrinology | Issue 1/2017

Abstract

Background

The purpose of this study was to determine the utilization and live birth rates of assisted reproductive technology (ART) modalities among various racial and ethnic groups in recent years.

Methods

We reviewed ART data reported to the Society for Assisted Reproductive Technologies Clinic Outcome Reporting System (SART CORS) for autologous ART and third-party ART (3ART) cycles which involved donor oocytes, sperm, embryos and gestational carrier, performed in the U.S. between 2004 and 2013. To gauge demand by various racial/ethnic groups for ART services, we examined fertility rates and demographics of the entire U.S. birth cohort over the same time interval.

Results

Of 1,132,844 autologous ART cycles 335,462 resulted in a live birth (29.6%). An additional, 217,030 3ART cycles resulted in 86,063 live births (39.7%). Hispanic and Black women demonstrated high fertility and lower utilization rates of autologous ART and 3ART. Caucasian and Asian women exhibited lower fertility rates and higher autologous ART and 3ART utilization. Autologous ART resulted in higher live birth rates among Caucasian and Hispanic women and lower rates among Asian and especially Black women. 3ART improved live birth rates in all races/ethnicities, though Black women experienced lower live birth rates with most modalities. Spontaneous abortion rates were higher among Black women following autologous ART and some 3ART modalities than those among Caucasian women.

Conclusion

Utilization of ART is inversely related to fertility rates. Autologous ART produces lower live birth rates among Asian and Black women. 3ART results in relatively low live birth rates among Black women.

Trial registration

SART CORS #57, Registered 5/14/2015

Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94(8):666–8.PubMedPubMedCentral

Wellons M, Fujimoto V, Baker V, et al. Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes. Fertil Steril. 2012;98:406–9.CrossRefPubMedPubMedCentral

Seifer DB, Frazier LM, Grainger DA. Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertil Steril. 2008;90(5):1701–10.CrossRefPubMed

Feinberg E, Larsen F, Catherino W, et al. Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in an equal-access-to-care setting. Fertil Steril. 2006;85(4):888–94.CrossRefPubMed

Seifer DB, Zackula R, Grainger DA. Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006. Fertil Steril. 2010;93(2):626–35.CrossRefPubMed

Purcell K, Schembri M, Frazier L, et al. Asian ethnicity is associated with reduced pregnancy outcomes after assisted-reproductive technology. Fertil Steril. 2007;87(2):297–302.CrossRefPubMed

Huddleston HG, Cedars MI, Sohn SH, et al. Racial and ethnic disparities in reproductive endocrinology and infertility. Am J Obstet Gynecol. 2010;202(5):413–9.CrossRefPubMed

Butts SF, Seifer DB. Racial and ethnic differences in reproductive potential across the life cycle. Fertil Steril. 2010;93(3):681–90.CrossRefPubMed

Langen ES, Shahine LK, Lamb JD, et al. Asian ethnicity and poor outcomes after in vitro fertilization blastocyst transfer. Obstet Gynecol. 2010;115(3):591–6.CrossRefPubMed

10.

Fujimoto V, Luke B, Brown M. Racial and ethnic disparities in assisted reproductive technology outcomes in the United States. Fertil Steril. 2010;93(2):382–290.CrossRefPubMed

11.

Kushnir VA, Yu Y, Barad DH, Weghofer A, Himaya E, Lee HJ, et al. Utilizing FMR1 gene mutations as predictors of treatment success in human in vitro fertilization. PLoS One. 2014;9(7):e102274.CrossRefPubMedPubMedCentral

12.

Gleicher N, Kushnir VA, Weghofer A, Barad DH. How the FMR1 gene became relevant to female fertility and reproductive medicine. Front Genet. 2014;5:284.CrossRefPubMedPubMedCentral

13.

Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotypes and subgenotypes of the FMR1 gene. Reprod Biol Endocrinol. 2012;10:77.CrossRefPubMedPubMedCentral

14.

Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. Reprod BioMed Online. 2010;20:485–91.CrossRefPubMed

15.

Gleicher N, Yu Y, Himaya E, Barad DH, Weghofer A, Wu YG, et al. Early decline in functional ovarian reserve in young women with low (CGG<26) FMR1 gene alleles. Transl Res. 2015;166(5):502–7.CrossRefPubMed

16.

Pastore LM, Young SL, Baker VL, Karns LB, Williams CD, Silverman LM. Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012;19:1226–31.CrossRefPubMedPubMedCentral

17.

Gustin SL, Ding VY, Desai M, Leader B, Baker VL. Evidence of an age-related correlation of ovarian reserve and FMR1 repeat number among women with "normal" CGG repeat status. J Assist Reprod Genet. 2015;32(11):1669–76.CrossRefPubMedPubMedCentral

18.

Shohat-Tal A, Sen A, Barad DH, Kushnir V, Gleicher N. Genetics of androgen metabolism in women with infertility and hypoandrogenism. Nat Rev Endocrinol. 2015;11(7):429–41.CrossRefPubMed

19.

Kawwass J, Monsour M, Crawford S, et al. Trends and outcomes for donor Oocyte cycles in the United States, 2000-2010. JAMA. 2013;310(22):2426–34.PubMedPubMedCentral

20.

Centers for Disease Control and Prevention, US Dept of Health and Human Services; Available at http://www.cdc.gov/art/artdata/index.html, Accessed on 8/1/16.

21.

Kushnir VA, Darmon SK, Shapiro AJ, Albertini DF, Barad DH, Gleicher N. Utilization of third party in vitro fertilization in the United States. Am J Obstet Gynecol. 2016; In press

22.

Martin J, Hamilton B, Osterman M, et al. Births: final data for 2013. National Vital Statistics Reports. 2015;64(1):1–65.

23.

Smith J, Eisenberg M, Glidden D, et al. Socioeconomic disparities in the utilization and success of fertility treatments: analysis of data from a prospective cohort in the United States. Fertil Steril. 2011;96(1):95–101.CrossRefPubMedPubMedCentral

24.

Ethics Committee of the American Society for Reproductive Medicine. Disparities in access to effective treatment for infertility in the United States: an ethics Committee opinion. Fertil Steril. 2015;104(5):1104–10.CrossRef

25.

Sobotka T, Skirbekk V, Philipov D. Economic recession and fertility in the developed world. Popul Dev Rev. 2011;37(2):267–306.CrossRefPubMed

26.

Mather M. Population Reference Bureau; World population data 2012; Available at http://www.prb.org/publications/datasheets/2012/world-population-data-sheet/fact-sheet-us-population.aspx; Accessed 11/2/16.

27.

Sharara F, McClamrock H. Differences in in vitro fertilization (IVF) outcomes between white and black women in an inner-city, university-based IVF program. Fertil Steril. 2000;73(6):1170–3.CrossRefPubMed

28.

Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anastos K, Watts DH, et al. Variations in serum mullerian inhibiting substance between white, black and hispanic women. Fertil Steril. 2009;92:1674–8.CrossRefPubMed

29.

Bleil ME, Gregorich SE, Adler NE, Sternfeld B, Rosen MP, Cedars MI. Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women. Fertil Steril. 2014;101(1):199–207.CrossRefPubMed

30.

Tal R, Seifer DB. Potential mechanisms for racial and ethnic differences in antimullerian hormone and ovarian reserve. Int J Endocrinol. 2013;2013:818912.CrossRefPubMedPubMedCentral

31.

Gleicher N, Weghofer A, Li J, Barad D. Differences in ovarian function parameters between Chinese and Caucasian oocyte donors: do they offer an explanation for lower IVF pregnancy rates in Chinese women? Hum Reprod. 2007;22(11):2879–82.CrossRefPubMed

32.

Gleicher N, Kim A, Barad DH, Shohat-Tal A, Lazzaroni E, Michaeli T, et al. FMR1-dependent variability of ovarian aging patterns is already apparent in young oocyte donors. Reprod Biol Endocrinol. 2013;11(1):80.CrossRefPubMedPubMedCentral

33.

Prizant H, Gleicher N, Sen A. Androgen actions in the ovary: balance is key. J Endocrinol. 2014;222(3):R141–51.CrossRefPubMed

34.

Perkins K, Boulet S, Jamieson D, et al. Trends and outcomes of gestational surrogacy in the United States. Fertil Steril. 2015;106(2):435–42.CrossRef

35.

Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol. 2015;125:5–12.CrossRefPubMed

36.

Seifer DB, Minkoff H, Merhi Z. Putting 'family' back in family planning. Hum Reprod. 2015;30(1):16–9.CrossRefPubMed

37.

Kushnir VA, Barad DH, Gleicher N. Ovarian reserve screening prior to contraception? Reprod BioMed Online. 2014;29(5):527–9.CrossRefPubMed

Title: Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA
Authors: Alice J. Shapiro
Sarah K. Darmon
David H. Barad
David F. Albertini
Norbert Gleicher
Vitaly A. Kushnir
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Reproductive Biology and Endocrinology / Issue 1/2017
Electronic ISSN: 1477-7827
DOI: https://doi.org/10.1186/s12958-017-0262-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA

Abstract

Background

Methods

Results

Conclusion

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2017

Polycystic ovary syndrome induced by exposure to testosterone propionate and effects of sympathectomy on the persistence of the syndrome

Testis specific histone 2B is associated with sperm chromatin dynamics and bull fertility-a pilot study

An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism

Association between TNF, IL1B, IL6, IL10 and IFNG polymorphisms and recurrent miscarriage: a case control study

Improving preimplantation genetic diagnosis (PGD) reliability by selection of sperm donor with the most informative haplotype

Low-dose lymphocyte immunotherapy rebalances the peripheral blood Th1/Th2/Treg paradigm in patients with unexplained recurrent miscarriage